Avita Medical, Inc. · NASDAQ:RCEL
Avita Medical — Q2 2024 Earnings Presentation
9 slides from Avita Medical's earnings presentation, Aug 9, 2024
Slide 1: Q2 2024 Earnings Presentation
NASDAQ: RCEL ASX: AVH Q2 2024 Earnings Presentation August 8, 2024
Slide 2: Forward-Looking Statements & Legal Disclaimers
Forward-Looking Statements & Legal Disclaimers 2024.Q4 v9 This presentation and the accompanying oral commentary are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this pre
Slide 3: Update on Full-Thickness Skin Defect Launch
Update on Full-Thickness Skin Defect Launch RECELL FOR FULL-THICKNESS SKIN DEFECTS ACCOUNT STATUS 60 52 50 Number of Accounts 40 37 31 30 22 20 10 6 0 Q1 2024 Q2 2024 QTD Q3 2024* New Accounts VAC Approved, No Order† VAC Evaluation Stage VAC Decision Stage * As of July 31, 2024 P3 † Value Analysis C
Slide 4: Maximizing Operating Room Efficiency with Multiple Devices
Maximizing Operating Room Efficiency with Multiple Devices Treating a burn injury 10% - 20% TBSA Treating a burn injury 20-30% TBSA Treating a burn injury 30-40% TBSA P4
Slide 5: How is RECELL GO Going?
How is RECELL GO Going? You can see for yourself. Treating a burn injury 50% - 60% TBSA P5
Slide 6: Strategic Transformation – Continuum of Wound Care
Strategic Transformation – Continuum of Wound Care CONTINUUM OF BURN AND FULL-THICKNESS SKIN DEFECT WOUND CARE Dermal Wound Scar Wound Depth Wound Bed Wound Bed Replacement/ Epidermal Dressings Reduction / Assessment Preparation Hemostasis Matrices/Skin Replacement Revision Substitutes Exploration E
Slide 7: Product Compatibility for Wound Care
Product Compatibility for Wound Care Clinical Presentation: full-thickness skin defect with concern for infection Dressing optimized for protection and moisture PermeaDerm by Stedical management RECELL + meshed split- Robust closure using significantly less skin thickness skin graft compared to trad
Slide 8: Quarterly Commercial Revenue
Quarterly Commercial Revenue STRONG COMMERCIAL GROWTH $25,000 Commercial Revenue (in thousands) $20,000 $19,500 1 $15,133 $15,000 $13,546 $14,097 $11,687 $11,069 $10,458 $10,000 $8,999 $9,364 40% 42% 51% 50% 6% 29% 44%1 Year-Over-Year Growth $5,000 $0 Ryan Zimmerman, BTIG (U.S.) Scott Power, Mor
Slide 9: Slide 9